BEIJING (Xinhua): The registration for clinical trials on the antiviral drug Remdesivir has been approved, and the first batch of pneumonia patients infected by the novel coronavirus (2019-nCoV) are expected to start taking the drug on Thursday (Feb 6), according to an official conference on Wednesday.
The approval is jointly supported by the Ministry of Science and Technology (MOST), the National Health Commission and the National Medical Products Administration.
BEIJING (Xinhua): The registration for clinical trials on the...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(2.56%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.0¢ | 1.9¢ | $5.784K | 301.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1399590 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.0¢ | 258837 | 6 |
View Market Depth
| Last trade - 15.33pm 14/11/2024 (20 minute delay) ? |
| BIT (ASX) Chart |